An 82-year-old woman with a history of congestive heart failure was admitted to this hospital for volume overload. Ascites, ...

An international collaborative study has identified the E2F2 protein as a potential new therapeutic target to prevent metabolic fatty liver disease from progressing towards more serious conditions, ...

The ultimate cause of death from cancer may not be metastatic disease, as researchers have long surmised, but an infiltration ...

Verzenio is the first contemporary therapy in over two decades to demonstrate a significant overall survival benefit in adjuvant HR+, HER2−, high-risk ...

The ultimate cause of death from cancer may not be metastatic disease, as researchers have long surmised, but an infiltration ...

A new study in eGastroenterology links gut dysbiosis with severe steatosis in metabolic dysfunction–associated steatotic ...

Primary overall survival analysis from the Phase 3 monarchE study of Verzenio (abemaciclib) in HR+HER2-, node-positive, high-risk early breast cancer to ...

A groundbreaking pig liver transplant in China saw a 71-year-old patient survive 171 days, with the pig organ providing ...

In a groundbreaking medical achievement, doctors in China successfully performed the world’s first pig liver transplant on a human, allowing the patient to survive for 171 days after the procedure.

In a medical first, Chinese doctors transplanted a genetically modified pig liver into a 71-year-old man, who survived 171 days, with the organ functi ...

Doctors in China say they transplanted a genetically modified pig liver into a 71-year-old man who lived 171 days after the ...